Antonios Douros

2.4k total citations
85 papers, 1.6k citations indexed

About

Antonios Douros is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Antonios Douros has authored 85 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Cardiology and Cardiovascular Medicine, 25 papers in Endocrinology, Diabetes and Metabolism and 14 papers in Surgery. Recurrent topics in Antonios Douros's work include Diabetes Treatment and Management (22 papers), Atrial Fibrillation Management and Outcomes (17 papers) and Blood Pressure and Hypertension Studies (16 papers). Antonios Douros is often cited by papers focused on Diabetes Treatment and Management (22 papers), Atrial Fibrillation Management and Outcomes (17 papers) and Blood Pressure and Hypertension Studies (16 papers). Antonios Douros collaborates with scholars based in Germany, Canada and United States. Antonios Douros's co-authors include Kristian B. Filion, Laurent Azoulay, Oriana Hoi Yun Yu, Samy Suissa, Hui Yin, Christel Renoux, Reinhold Kreutz, Sophie Dell’Aniello, Ralf Stahlmann and Edeltraut Garbe and has published in prestigious journals such as Annals of Internal Medicine, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Antonios Douros

78 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antonios Douros Germany 24 556 330 267 252 204 85 1.6k
Liberata Sportiello Italy 24 363 0.7× 149 0.5× 251 0.9× 235 0.9× 145 0.7× 76 1.6k
Zhigang Zhao China 23 247 0.4× 237 0.7× 225 0.8× 172 0.7× 232 1.1× 108 1.6k
R. Lassalle France 22 221 0.4× 252 0.8× 158 0.6× 260 1.0× 240 1.2× 98 2.4k
Matthijs L. Becker Netherlands 21 394 0.7× 288 0.9× 439 1.6× 519 2.1× 119 0.6× 62 1.8k
Mordechai Muszkat Israel 25 433 0.8× 664 2.0× 211 0.8× 332 1.3× 239 1.2× 105 2.4k
Morten Hansen Denmark 17 420 0.8× 153 0.5× 301 1.1× 257 1.0× 224 1.1× 45 1.2k
Ana Filipa Macedo Portugal 14 460 0.8× 449 1.4× 970 3.6× 182 0.7× 177 0.9× 20 2.1k
Annamaria Mascolo Italy 24 231 0.4× 270 0.8× 173 0.6× 168 0.7× 94 0.5× 64 1.2k
Michel Andréjak France 22 179 0.3× 426 1.3× 396 1.5× 210 0.8× 117 0.6× 115 1.6k
Massimo Boemi Italy 23 1.1k 2.0× 405 1.2× 417 1.6× 469 1.9× 264 1.3× 71 2.4k

Countries citing papers authored by Antonios Douros

Since Specialization
Citations

This map shows the geographic impact of Antonios Douros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonios Douros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonios Douros more than expected).

Fields of papers citing papers by Antonios Douros

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonios Douros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonios Douros. The network helps show where Antonios Douros may publish in the future.

Co-authorship network of co-authors of Antonios Douros

This figure shows the co-authorship network connecting the top 25 collaborators of Antonios Douros. A scholar is included among the top collaborators of Antonios Douros based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonios Douros. Antonios Douros is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Douros, Antonios, et al.. (2025). Masking in Active Comparator Designs in Pharmacovigilance: A Retrospective Bias Analysis on the Spontaneous Reporting of Thiazolidinediones and Cardiovascular Events. Pharmacoepidemiology and Drug Safety. 34(1). e70102–e70102. 1 indexed citations
2.
Wang, Wanqi, et al.. (2025). Safety of concomitant use of oral anticoagulants and antidiabetic drugs: a systematic review of observational studies. Expert Opinion on Drug Metabolism & Toxicology. 21(5). 617–624.
3.
Douros, Antonios, Ying Cui, Sophie Dell’Aniello, Samy Suissa, & Paul Brassard. (2025). Influenza Immunization at Midlife and the Risk of Parkinson Disease. JAMA Network Open. 8(12). e2547140–e2547140.
4.
Chen, Cheng, Sean Hennessy, Charles E. Leonard, et al.. (2025). Evaluation of Drug–Drug Interactions in Pharmacoepidemiologic Research. Pharmacoepidemiology and Drug Safety. 34(1). e70088–e70088. 4 indexed citations
5.
Riemer, Thomas, et al.. (2025). Effectiveness and safety of concomitant use of direct oral anticoagulants and antiarrhythmic drugs: a systematic review of observational studies. European Journal of Clinical Pharmacology. 81(10). 1409–1419.
6.
Wang, Wanqi, Ying Cui, Oriana Hoi Yun Yu, Samy Suissa, & Antonios Douros. (2024). The Prevalent New‐User Design to Study Drug–Drug Interactions: The Example of Sulfonylureas and Warfarin Interaction on the Risk of Severe Hypoglycemia. Pharmacoepidemiology and Drug Safety. 33(10). e70014–e70014. 3 indexed citations
7.
Salmasi, Shahrzad, et al.. (2024). Opioid Use and the Risk of Ventricular Arrhythmias: A Systematic Review and Meta‐Analysis. Pharmacoepidemiology and Drug Safety. 33(8). e5854–e5854. 2 indexed citations
8.
Douros, Antonios, et al.. (2024). Comparative risk of infection of medications used for type 2 diabetes. Expert Opinion on Drug Safety. 23(9). 1079–1091. 4 indexed citations
9.
Douros, Antonios, Ying Cui, Robert W. Platt, et al.. (2024). Effectiveness and safety of direct oral anticoagulants among patients with non-valvular atrial fibrillation and liver disease: A multinational cohort study. Thrombosis Research. 237. 71–78. 11 indexed citations
10.
11.
Reynier, Pascal, et al.. (2023). Sulphonylureas versus metformin and the risk of ventricular arrhythmias among people with type 2 diabetes: A population‐based cohort study. Diabetes Obesity and Metabolism. 25(6). 1523–1533. 5 indexed citations
12.
13.
Cui, Ying, et al.. (2023). Pharmacologic Heterogeneity and Risk of Severe Hypoglycemia with Concomitant Use of Sulfonylureas and DPP‐4 Inhibitors: Population‐Based Cohort Study. Clinical Pharmacology & Therapeutics. 114(3). 712–720. 5 indexed citations
14.
15.
Douros, Antonios, Carlo A Fallone, Laurent Azoulay, et al.. (2023). Clinically apparent Helicobacter pylori infection and the risk of incident Alzheimer's disease: A population‐based nested case‐control study. Alzheimer s & Dementia. 20(3). 1716–1724. 15 indexed citations
16.
Yu, Ya‐Hui, Han Eol Jeong, Robert W. Platt, et al.. (2022). Challenges in evaluating treatments for COVID-19: The case of in-hospital anticoagulant use and the risk of adverse outcomes. Frontiers in Pharmacology. 13. 1034636–1034636. 2 indexed citations
17.
Douros, Antonios, et al.. (2021). Effectiveness and safety of direct oral anticoagulants in patients with cancer associated venous thromboembolism. Thrombosis Research. 202. 128–133. 8 indexed citations
18.
Kreutz, Reinhold, Engi Algharably, & Antonios Douros. (2019). Reviewing the effects of thiazide and thiazide-like diuretics as photosensitizing drugs on the risk of skin cancer. Journal of Hypertension. 37(10). 1950–1958. 50 indexed citations
19.
Abrahami, Devin, Antonios Douros, Hui Yin, et al.. (2018). Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study. BMJ. 363. k4880–k4880. 47 indexed citations
20.
Douros, Antonios, Christel Renoux, Janie Coulombe, & Samy Suissa. (2017). Patterns of long‐term use of non‐vitamin K antagonist oral anticoagulants for non‐valvular atrial fibrillation: Quebec observational study. Pharmacoepidemiology and Drug Safety. 26(12). 1546–1554. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liberata Sportiello Breakdown of academic impact, for papers by Zhigang Zhao Breakdown of academic impact, for papers by R. Lassalle Breakdown of academic impact, for papers by Matthijs L. Becker Breakdown of academic impact, for papers by Mordechai Muszkat Breakdown of academic impact, for papers by Morten Hansen Breakdown of academic impact, for papers by Ana Filipa Macedo Breakdown of academic impact, for papers by Annamaria Mascolo Breakdown of academic impact, for papers by Michel Andréjak Breakdown of academic impact, for papers by Massimo Boemi
Rankless by CCL
2026